Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion

This publication has 185 references indexed in Scilit:

• Creation of immune ‘stealth’ genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1
  Gene Therapy, 2003
• Expression of the Adenovirus Receptor and Its Interaction with the Fiber Knob
  Experimental Cell Research, 2000
• Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
  Gene Therapy, 1999
• Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression
  Gene Therapy, 1997
• Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal Period
  Published by Elsevier ,1996
• FK506 Immunosuppression to Control the Immune Reactions Triggered by First-Generation Adenovirus-Mediated Gene Transfer
  Human Gene Therapy, 1995
• The influence of IL12 on the development of Th11 and Th2 cells and its adjuvant effect for humoral immune responses
  Research in Immunology, 1995
• Immunosuppression by FK506 Markedly Prolongs Expression of Adenovirus-Delivered Transgene in Skeletal Muscles of Adult Dystrophic [mdx] Mice
  Biochemical and Biophysical Research Communications, 1995
• Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2a
  Human Gene Therapy, 1994
• Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis
  Nature Genetics, 1994